Aptevo Therapeutics Inc. - Common Stock (APVO)

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.

Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.

Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!

Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Aptevo stock spikes as new AML trial data show 85% remission rate with mipletamig triplet therapy, supported by strong safety and no CRS observed.

The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Discover the top movers in Monday's pre-market session and stay informed about market dynamics.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.